These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 18053152)
1. Nanotechnology-based drug delivery systems. Suri SS; Fenniri H; Singh B J Occup Med Toxicol; 2007 Dec; 2():16. PubMed ID: 18053152 [TBL] [Abstract][Full Text] [Related]
2. Nasal-nanotechnology: revolution for efficient therapeutics delivery. Kumar A; Pandey AN; Jain SK Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207 [TBL] [Abstract][Full Text] [Related]
3. Nanosize drug delivery system. Mukherjee B Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648 [TBL] [Abstract][Full Text] [Related]
4. Nanobiotechnology-based drug delivery in brain targeting. Dinda SC; Pattnaik G Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011 [TBL] [Abstract][Full Text] [Related]
5. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. Jain AK; Das M; Swarnakar NK; Jain S Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514 [TBL] [Abstract][Full Text] [Related]
6. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics. Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734 [TBL] [Abstract][Full Text] [Related]
7. Carbon nanotubes for delivery of small molecule drugs. Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Feng SS; Mu L; Win KY; Huang G Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide. Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614 [TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411 [TBL] [Abstract][Full Text] [Related]
11. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab. Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558 [TBL] [Abstract][Full Text] [Related]
12. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
13. Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials. Tsou YH; Zhang XQ; Zhu H; Syed S; Xu X Small; 2017 Nov; 13(43):. PubMed ID: 29045030 [TBL] [Abstract][Full Text] [Related]
14. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620 [TBL] [Abstract][Full Text] [Related]
15. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. Caban-Toktas S; Sahin A; Lule S; Esendagli G; Vural I; Karlı Oguz K; Soylemezoglu F; Mut M; Dalkara T; Khan M; Capan Y Int J Pharm; 2020 Mar; 578():119076. PubMed ID: 31988035 [TBL] [Abstract][Full Text] [Related]
16. Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy. Cui Y; Zhang M; Zeng F; Jin H; Xu Q; Huang Y ACS Appl Mater Interfaces; 2016 Nov; 8(47):32159-32169. PubMed ID: 27808492 [TBL] [Abstract][Full Text] [Related]
17. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice. Kefayat A; Vaezifar S Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043 [TBL] [Abstract][Full Text] [Related]
18. Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples. Zhang RX; Li J; Zhang T; Amini MA; He C; Lu B; Ahmed T; Lip H; Rauth AM; Wu XY Acta Pharmacol Sin; 2018 May; 39(5):825-844. PubMed ID: 29698389 [TBL] [Abstract][Full Text] [Related]
19. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy. Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955 [TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]